Global Neurosurgery Market, By Product Type (Neurosurgery Devices, Neurosurgery Software, Consumables), Application (Aneurysms, Arteriovenous Malformation (AVM), Brain Tumors, Carotid Artery Blockage/Stenosis, Cerebrovascular Surgery, Cortical Mapping, Epilepsy, Functional Neurosurgery, Intraoperative Angiography, Parkinson's Disease and Tremors, Peripheral Nerve Surgery, Pituitary Tumors, Radiosurgery, Skull Base Surgery, Spine Surgery, Stereotactic Neurosurgery, Trauma Surgery, Trigeminal Neuralgia, Others), Age Group (Pediatric, Adult, Geriatric), End User (Hospitals, Neurosurgery Centers, Research Centers, Ambulatory Surgical Centers, Others), Distribution Channel (Direct Tender, Third Party Distributors, Others) Industry Trends and Forecast to 2029
Neurosurgery Market Analysis and Insights
Technological innovation within healthcare may be defined as the introduction of a new technology that initiates a change in clinical practice. Neurosurgery is a particularly technologically intensive surgical discipline, and new technologies have preceded many of the major advances in operative neurosurgical techniques. The present focus is on developing minimally-invasive devices that could decrease the probability of complications during operative sessions. With the introduction of minimally-invasive techniques, doctors are using highly specialized surgical instruments such as power tools, neurovascular embolization devices, and radiosurgery systems such as gamma-knife.
In addition, a set of new factors, such as enhanced regulatory standards and an increasing incidence of neurological diseases, has led to an increase in the adoption of advanced treatment protocols and the assumption that such therapies will be available more widely. This has increased industry and government demand for zero deviations, which has driven the demand for neurosurgical services, and an increase in cross-industry alliances and collaborations is a major factor expected to boost the neurosurgery market. However, the higher costs involved in neuro endoscopy equipment and procedures, along with the lack of trained professionals, may restrain the market growth in the forecast period.
Data Bridge Market Research analyzes that the global neurosurgery market is expected to reach the value of USD 20,679.72 million by 2029, at a CAGR of 14.2% during the forecast period. "Product type" accounts for the largest type segment in the market due to the increasing patient population globally. This market report also covers pricing analysis, patent analysis, and technological advancements in depth.
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2019-2014) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
全球神经外科市场，按产品类型（神经外科设备、神经外科软件、耗材）、应用（动脉瘤、动静脉畸形 (AVM)、脑肿瘤、颈动脉阻塞/狭窄、脑血管外科、皮质映射、癫痫、功能性神经外科、术中血管造影、帕金森病和震颤、周围神经外科、垂体瘤、放射外科、颅底手术、脊柱外科、立体定向神经外科、创伤外科、三叉神经痛等）、年龄组（儿科、成人、老年）、最终用户（医院、神经外科中心、研究中心、门诊手术中心等）分销渠道（直接招标、第三方分销商等） |
|
覆盖国家 |
美国、加拿大、墨西哥、德国、法国、英国、意大利、西班牙、俄罗斯、土耳其、比利时、荷兰、瑞士和欧洲其他地区、中国、日本、印度、韩国、新加坡、泰国、马来西亚、澳大利亚、菲律宾、印度尼西亚和亚太其他地区、阿联酋、以色列、南非、沙特阿拉伯、埃及和中东和非洲其他地区、巴西、阿根廷和南美洲其他地区 |
|
涵盖的市场参与者 |
Medtronic、Abbott、Boston Scientific Corporation 或其附属公司、Elekta、ALEVA NEUROTHERAPEUTICS、Machida Endoscope Co., Ltd.、Brainlab AG、adeor medical AG.、LivaNova PLC、B. Braun SE、Optofine Instruments Pvt. Ltd.、Wallaby Medical、Terumo Medical Corporation、NEVRO CORP.、Integra LifeSciences、Stryker、Penumbra, Inc.、KARL STORZ SE & Co. KG、Nalu Medical, Inc.、Renishaw plc.、Synapse Biomedical Inc.、EMS Handels Gesellschaft mbH、Inomed Medizintechnik GmbH、BIOINDUCTION、ANT Neuro、Advantis Medical Imaging 和 Leica Microsystems 等 |
全球神经外科市场定义
神经系统疾病包括痴呆、头痛症、神经感染和多发性硬化症、创伤性脑损伤、与神经系统疾病相关的疼痛、与营养不良相关的神经系统疾病、中风、癫痫和帕金森病。这些疾病是致命的，无法通过治疗治愈。一些神经外科设备包括神经内窥镜、立体定向系统、导管、起搏器、单腔和双腔除颤器、植入式心脏复律除颤器等，用于各种神经外科手术。神经外科有助于诊断患有脑瘤、事故引起的脊髓损伤、颈部和背部不适以及脊髓液运动异常的患者。全世界约有 700 万至 1000 万人患有帕金森病。神经系统疾病是全球发病和残疾的主要原因之一。在预测期内，神经外科的技术发展预计将推动市场发展。人口中神经系统疾病发病率和患病率的上升以及神经外科手术相对于其他传统手术的优势预计将推动全球神经外科手术市场的增长。此外，神经外科手术的进步，如脑肿瘤手术的三维重建、脑病变的X刀放射手术、脑肿瘤的MRI和脑肿瘤局部麻醉手术，预计将为神经外科手术市场的增长提供丰厚的机会。
全球神经外科市场动态
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容：
驱动程序
- 神经外科的技术进步
自现代神经外科诞生以来，技术进步为更彻底、更深入地了解大脑形态和功能铺平了道路，从而更有效地治疗影响患者的复杂病症。技术进步带来了从传统设备向基于新技术的节能设备的转变。几种尖端技术很容易帮助神经外科。神经外科是一门技术密集型的外科学科，新技术先于手术神经外科技术的许多重大进步。图像引导和神经调节设备在专利和出版物方面表现出高度相关的快速增长，表明它们是技术扩展领域，预计将推动市场增长。
随着神经系统疾病患病率的上升，对神经外科的需求也随之增加。预计市场在预测期内将有所增长。
此外，内窥镜技术的采用是市场的一个重大进步。此外，神经外科手术的恢复时间更短。因此，所有这些因素都有望成为市场增长的驱动力。
- 神经系统疾病患病率上升
世界卫生组织 (WHO) 专注于对促进公共卫生至关重要的领域的研究。最近，WHO 特别关注那些对世界造成沉重负担的常见且致残的神经系统疾病。神经系统疾病发生在所有年龄组和不同地理区域。它们对世界各地的发病率和死亡率有重大影响。预计未来十年，中低收入国家 (LMIC) 的神经系统疾病负担将呈指数级增长。
经鼻出血、脑出血 (ICH)、创伤性脑损伤、慢性疼痛、抑郁症和帕金森氏症等神经系统疾病的患病率不断上升，预计将推动市场增长。
因此，越来越多的神经系统疾病（如鼻腔出血和脑出血 (ICH)）正在推动市场增长。神经系统疾病已成为重大公共卫生危机，预计将推动全球神经外科市场的增长。
克制
- 神经外科手术和设备费用高昂
近年来，神经外科产品的成本显著增加，医院和神经外科中心等最终用户不得不承担这一成本。神经血管栓塞装置、神经血管栓塞装置和神经内窥镜等产品价格相当昂贵。制造商也投入更多资源进行研发，以引进具有成本效益的先进技术。一些复杂的神经外科手术需要大量时间和精力，而且风险也很大。这些复杂的程序需要先进的技术和技能，因此设备和神经外科手术的成本增加。这些设施的维护和对电力供应的持续需求增加了手术成本。减压开颅术治疗创伤性脑损伤 (TBI) 是一项昂贵的程序，并且发病率和死亡率很高。
与神经外科手术相关的成本相当高，预计这会成为市场增长的制约因素。
机会
- 提高对神经系统疾病的认识
随着全球人口的增长，老年人口中很大一部分受到神经系统疾病的影响，例如癫痫、帕金森病、中风、脑瘤、痴呆和多发性硬化症等。因此，了解神经系统疾病很重要，了解神经系统疾病可以促使人们寻求医疗帮助，从而得到正确的诊断和有效的治疗。所有神经系统疾病占 82.8%。巨大的增长增加了神经系统疾病的负担，这可以归因于对神经系统疾病和治疗缺乏认识，导致延迟发现，以及无法获得优质的医疗保健和康复中心。不断增加的医疗保健计划以及政府和公共医疗保健机构的资金增加有助于减轻神经系统疾病的负担，并开发有利于市场增长的神经系统产品。
提高对神经系统疾病的认识对神经外科市场有利。在大多数地区，许多政府和非政府机构都开展了一些提高认识的计划，以便及早发现神经系统疾病。
挑战
- 神经系统疾病的替代疗法
药物疗法是治疗神经系统疾病的第一线治疗方法。只有当非手术治疗无效时，才会选择神经外科手术。补充和替代疗法越来越多地用于补充神经外科治疗。这包括针灸、自然疗法、脊椎按摩疗法和阿育吠陀医学等。最近，医生越来越接受使用替代疗法，国家卫生研究院对补充和替代方案的安全性和有效性进行了科学研究，这可能会对神经外科市场的增长构成挑战。
因此，替代治疗方案预计将对全球神经外科市场带来重大挑战。
新冠肺炎疫情对全球神经外科市场的影响
COVID-19 疫情对全球医疗保健产生了巨大影响，英国、美国、中国、南非等国家是受影响最严重的国家。由于该领域的研究活动暂时停止，再加上医院和诊断中心的患者流入量低，疫情对神经外科市场的增长产生了负面影响。此外，COVID-19 疫情对神经外科产品交付的影响对神经外科医生获得外科产品的交付提出了挑战。
制造商正在制定各种战略决策，以在新冠疫情后实现复苏。参与者正在进行多项研发活动和产品发布，并建立战略合作伙伴关系，以改进神经外科市场的技术。
最新动态
- 2022 年 3 月，医疗技术领域的领导者美敦力宣布在 TITAN 2 关键研究中进行了首批患者植入，该研究评估了美敦力的试验性植入式胫骨神经调节 (TNM) 装置对膀胱过度活动症 (OAB) 患者的安全性和有效性。植入式 TNM 有可能通过一种新方法为数百万膀胱失禁患者带来缓解，这种方法为医生和患者提供了更大的便利和更多的选择。这将有助于该公司评估其产品的安全性和有效性
- 2022 年 4 月，雅培宣布推出 NeuroSphere myPath 数字健康应用的升级版，该应用具有增强的功能，可帮助医生在患者试用雅培神经刺激设备治疗慢性疼痛时更密切地跟踪患者。此次升级是雅培对互联护理技术的承诺的一部分，旨在让人们掌控自己的健康并促进与医生的更好沟通。通过推出该应用，该公司增强了产品的使用
- 2022 年 4 月，波士顿科学公司或其附属公司宣布其最新的图像引导编程软件 Vercise Neural Navigator 已获得美国食品药品监督管理局 (FDA) 批准，该软件带有 STIMVIEW XT。与领先的软件驱动医疗技术公司 Brainlab AG 合作开发。这有助于该公司扩大其产品组合
- 2020 年 10 月，Accuray Incorporated 宣布与数字手术和精准放射治疗领域的市场领导者 Brainlab AG 合作，这将增强和扩展 Accuray CyberKnife 治疗平台在神经放射外科市场的应用。两家公司合作为神经放射外科社区提供 Brainlab Elements 规划软件，该软件将提供针对神经外科医生优化的轮廓勾画功能。这有助于该公司扩大业务
全球神经外科市场范围
全球神经外科市场细分为产品类型、应用、年龄组、最终用户和分销渠道。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
按产品类型
- 神经外科设备
- 神经外科软件
- 耗材
根据产品类型，全球神经外科市场分为神经外科设备、神经外科软件和消耗品。
按应用
- 动脉瘤
- 动静脉畸形 (AVM)
- 脑肿瘤
- 颈动脉阻塞/狭窄
- 脑血管外科
- 皮质映射
- 癫痫
- 功能神经外科
- 术中血管造影
- 帕金森病和震颤
- 周围神经手术
- 垂体瘤
- 放射外科
- 颅底手术
- 脊柱手术
- 立体定向神经外科手术
- 创伤手术
- 三叉神经痛
- 其他的
根据应用，全球神经外科市场细分为动脉瘤、动静脉畸形 (AVM)、脑肿瘤、颈动脉阻塞/狭窄、脑血管外科、皮质映射、癫痫、功能性神经外科、术中血管造影、帕金森病和震颤、周围神经外科、垂体瘤、放射外科、颅底手术、脊柱外科、立体定向神经外科、创伤手术、三叉神经痛等。
按年龄组
- 儿科
- 成人
- 老年
根据最终用户，全球神经外科市场分为儿科、成人和老年科。
按最终用户
- 医院
- 研究中心
- 神经外科中心
- 门诊手术中心（ASCS）
- 其他的
根据最终用户，全球神经外科市场分为医院、神经外科中心、研究中心、门诊手术中心和其他。
按分销渠道
- 直接招标
- 第三方分销商
- 其他的
根据分销渠道，全球神经外科市场分为直接招标、第三方分销商和其他。
全球神经外科市场区域分析/见解
对全球神经外科市场进行分析，并按产品类型、应用、年龄组、最终用户和分销渠道提供市场规模信息。
本市场报告涵盖的国家包括美国、加拿大、墨西哥、德国、法国、英国、意大利、西班牙、俄罗斯、土耳其、比利时、荷兰、瑞士、欧洲其他地区、中国、日本、印度、韩国、新加坡、泰国、马来西亚、澳大利亚、菲律宾、印度尼西亚、亚太其他地区、阿联酋、以色列、南非、沙特阿拉伯、埃及、中东和非洲其他地区、巴西、阿根廷和南美洲其他地区。
2022 年，北美预计将主导全球神经外科市场，因为北美是最大的消费市场，GDP 较高，拥有主要市场参与者。由于神经外科设备技术进步的提高，美国预计将实现增长。研发投资的增加和神经外科作为制定治疗方案的一种选择的日益普及，预计将推动市场增长。由于 Terumo Medical Corporation、NEVRO CORP.、Integra LifeSciences、Stryker 等先进技术提供商的强大影响力，美国在北美地区占据主导地位。由于新兴市场需求的增加和医疗保健行业的扩张，英国预计将主导欧洲地区。由于医疗保健支出的增加，中国预计将主导亚太地区。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战，以及销售渠道的影响。
竞争格局和全球神经外科市场份额分析
全球神经外科市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对全球神经外科市场的关注有关。
全球神经外科市场的一些主要参与者包括美敦力、雅培、波士顿科学公司或其附属公司、Elekta、ALEVA NEUROTHERAPEUTICS、Machida Endoscope Co., Ltd.、Brainlab AG、adeor medical AG.、LivaNova PLC、B. Braun SE、Optofine Instruments Pvt. Ltd.、Wallaby Medical、Terumo Medical Corporation、NEVRO CORP.、Integra LifeSciences、Stryker、Penumbra, Inc.、KARL STORZ SE & Co. KG、Nalu Medical, Inc.、Renishaw plc.、Synapse Biomedical Inc.、EMS Handels Gesellschaft mbH、Inomed Medizintechnik GmbH、BIOINDUCTION、ANT Neuro、Advantis Medical Imaging 和 Leica Microsystems 等。
研究方法：全球神经外科市场
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域以及供应商份额分析。如有进一步询问，请要求分析师致电。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL NEUROSURGERY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 SOURCE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 INDUSTRIAL INSIGHTS:
4.4 CONCLUSION
5 REGULATIONS OF THE GLOBAL NEUROSURGERY MARKET
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 TECHNOLOGICAL ADVANCEMENT IN NEUROSURGERY
6.1.2 RISING PREVALENCE OF NEUROLOGICAL CONDITIONS
6.1.3 DEVELOPMENTS IN SURGICAL EQUIPMENT
6.2 RESTRAINTS
6.2.1 THE HIGH COST ASSOCIATED WITH NEUROSURGERIES AND EQUIPMENT
6.2.2 UNFAVOURABLE REIMBURSEMENT POLICIES
6.3 OPPORTUNITIES
6.3.1 RISING AWARENESS ABOUT NEUROLOGICAL DISORDERS
6.3.2 INCREASING NUMBER OF KEY PLAYERS IN MARKET
6.3.3 ADVANCE PRODUCT DEVELOPMENT AND LAUNCHES IN RECENT YEARS
6.4 CHALLENGES
6.4.1 ALTERNATIVE TREATMENTS FOR NEUROLOGICAL DISEASE
6.4.2 STRINGENT REGULATIONS FOR APPROVAL OF MEDICAL DEVICES
7 GLOBAL NEUROSURGERY MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 NEUROSURGERY DEVICES
7.2.1 NEUROMODULATION DEVICES
7.2.1.1 INTERNAL NEUROMODULATION DEVICES
7.2.1.1.1 SPINAL CORD STIMULATION DEVICES
7.2.1.1.1.1 RECHARGEABLE
7.2.1.1.1.2 NON- RECHARGEABLE
7.2.1.1.2 DEEP BRAIN STIMULATION DEVICES
7.2.1.1.2.1 SINGLE-CHANNEL DEEP BRAIN STIMULATION
7.2.1.1.2.2 DUAL-CHANNEL DEEP BRAIN STIMULATION
7.2.1.1.3 SACRAL NERVE STIMULATION DEVICES
7.2.1.1.3.1 IMPLANTABLE
7.2.1.1.3.2 EXTERNAL
7.2.1.1.4 VAGUS NERVE STIMULATION DEVICES
7.2.1.1.4.1 INVASIVE
7.2.1.1.4.2 EXTERNAL
7.2.1.1.5 GASTRIC ELECTRICAL STIMULATION DEVICES
7.2.1.1.5.1 LOW FREQUENCY GASTRIC ELECTRICAL STIMULATORS
7.2.1.1.5.2 HIGH FREQUENCY GASTRIC ELECTRICAL STIMULATORS
7.2.1.1.6 EXTERNAL NEUROMODULATION DEVICES
7.2.1.1.6.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)
7.2.1.1.6.2 TRANSCRANIAL MAGNETIC STIMULATION (TMS)
7.2.1.1.6.3 OTHERS
7.2.2 NEURO-INTERVENTIONAL DEVICES
7.2.2.1 EMBOLIZATION COILS
7.2.2.1.1 DETACHABLE
7.2.2.1.2 PUSHABLE
7.2.2.2 CAROTID STENTS
7.2.2.3 INTRACRANIAL STENTS
7.2.2.4 NEUROVASCULAR THROMBECTOMY
7.2.2.4.1 COIL RETRIEVERS
7.2.2.4.2 ASPIRATION DEVICES
7.2.2.4.3 STENT RETRIEVERS
7.2.2.5 INTRASSACULAR DEVICES
7.2.2.6 BALLOONS
7.2.2.7 OTHERS
7.2.3 NEUROSURGERY SURGICAL POWER TOOLS
7.2.3.1 DRILL
7.2.3.1.1 PNEUMATIC NEUROSURGICAL DRILLS
7.2.3.1.2 ELECTRICAL NEUROSURGICAL DRILLS
7.2.3.2 SAW
7.2.3.3 OTHERS
7.2.4 NEUROSURGICAL NAVIGATION SYSTEMS
7.2.5 CEREBROSPINAL FLUID (CSF) MANAGEMENT DEVICES
7.2.5.1 CSF SHUNTS
7.2.5.2 EXTERNAL DRAINAGE SYSTEM
7.2.6 NEUROSURGICAL MICROSCOPE
7.2.7 CRANIAL STABILIZATION
7.2.8 NEUROENDOSCOPY DEVICES
7.2.9 INTRA OPERATIVE IMAGING
7.2.10 BRAIN MONITORING
7.2.11 NEUROSURGICAL EVACUATION DEVICES
7.2.12 STEREOTACTIC SYSTEMS
7.2.13 ULTRASONIC ASPIRATOR
7.2.14 BIPOLAR EQUIPMENT
7.3 NEUROSURGERY SOFTWARE
7.3.1 IMAGING NEUROSURGERY SOFTWARE
7.3.2 PRE-OPERATION PLANNING NEUROSURGERY SOFTWARE
7.3.3 OTHERS
7.4 CONSUMABLES
8 GLOBAL NEUROSURGERY MARKET, BY AGE GROUP
8.1 OVERVIEW
8.2 PEDIATRIC
8.3 ADULT
8.4 GERIATRIC
9 GLOBAL NEUROSURGERY MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 BRAIN TUMORS
9.3 TRAUMA SURGERY
9.4 SPINE SURGERY
9.5 PARKINSON’S DISEASE AND TREMORS
9.6 PERIPHERAL NERVE SURGERY
9.7 EPILEPSY
9.8 FUNCTIONAL NEUROSURGERY
9.9 CAROTID ARTERY BLOCKAGE/STENOSIS
9.1 INTRAOPERATIVE ANGIOGRAPHY
9.11 CEREBROVASCULAR SURGERY
9.12 ANEURYSMS
9.13 PITUITARY TUMORS
9.14 RADIOSURGERY
9.15 STEREOTACTIC NEUROSURGERY
9.16 CORTICAL MAPPING
9.17 ARTERIOVENOUS MALFUNCTION (AVM)
9.18 SKULL BASE SURGERY
9.19 TRIGEMINAL NEURALGIA
9.2 OTHERS
10 GLOBAL NEUROSURGERY MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.2.1 ACUTE CARE HOSPITALS
10.2.2 LONG-TERM CARE HOSPITALS
10.2.3 NURSING FACILITIES
10.2.4 REHABILITATION CENTERS
10.3 RESEARCH CENTERS
10.4 NEUROSURGERY CENTERS
10.5 AMBULATORY SURGICAL CENTERS (ASCS)
10.6 OTHERS
11 GLOBAL NEUROSURGERY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 THIRD PARTY DISTRIBUTORS
11.4 OTHERS
12 GLOBAL NEUROSURGERY MARKET, BY REGION
12.1 OVERVIEW
12.2 NORTH AMERICA
12.2.1 U.S.
12.2.2 CANADA
12.2.3 MEXICO
12.3 EUROPE
12.3.1 GERMANY
12.3.2 FRANCE
12.3.3 U.K.
12.3.4 ITALY
12.3.5 RUSSIA
12.3.6 SPAIN
12.3.7 TURKEY
12.3.8 NETHERLANDS
12.3.9 SWITZERLAND
12.3.10 BELGIUM
12.3.11 REST OF EUROPE
12.4 ASIA-PACIFIC
12.4.1 CHINA
12.4.2 JAPAN
12.4.3 SOUTH KOREA
12.4.4 INDIA
12.4.5 AUSTRALIA
12.4.6 SINGAPORE
12.4.7 THAILAND
12.4.8 MALAYSIA
12.4.9 INDONESIA
12.4.10 PHILIPPINES
12.4.11 REST OF ASIA-PACIFIC
12.5 SOUTH AMERICA
12.5.1 BRAZIL
12.5.2 ARGENTINA
12.5.3 REST OF SOUTH AMERICA
12.6 MIDDLE EAST AND AFRICA
12.6.1 SOUTH AFRICA
12.6.2 SAUDI ARABIA
12.6.3 UAE
12.6.4 EGYPT
12.6.5 ISRAEL
12.6.6 REST OF MIDDLE EAST AND AFRICA
13 GLOBAL NEUROSURGERY MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: GLOBAL
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
13.3 COMPANY SHARE ANALYSIS: EUROPE
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 MEDTRONIC
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 STRYKER
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 ABBOTT
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 BOSTON SCIENTIFIC CORPORATION OR ITS AFFILIATES.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 INTEGRA LIFESCIENCES (2021)
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 ADEOR MEDICAL AG
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENTS
15.7 ADVANTIS MEDICAL IMAGING
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 ALEVA NEUROTHERAPEUTICS
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENTS
15.9 ANT NEURO
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.1 B. BRAUN SE
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENTS
15.11 BIOINDUCTION
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 BRAINLAB AG
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENTS
15.13 ELEKTA
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENTS
15.14 EMS HANDELS GESELLSCHAFT MBH
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 INOMED MEDIZINTECHNIK GMBH
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 KARL STORZ SE & CO. KG
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 LEICA MICROSYSTEMS
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.18 LIVANOVA PLC
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENTS
15.19 NEVRO CORP.
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENTS
15.2 OPTOFINE INSTRUMENTS PVT. LTD.
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENTS
15.21 PENUMBRA, INC.
15.21.1 COMPANY SNAPSHOT
15.21.2 REVENUE ANALYSIS
15.21.3 PRODUCT PORTFOLIO
15.21.4 RECENT DEVELOPMENTS
15.22 RENISHAW PLC.
15.22.1 COMPANY SNAPSHOT
15.22.2 REVENUE ANALYSIS
15.22.3 PRODUCT PORTFOLIO
15.22.4 RECENT DEVELOPMENT
15.23 SYNAPSE BIOMEDICAL INC.
15.23.1 COMPANY SNAPSHOT
15.23.2 PRODUCT PORTFOLIO
15.23.3 RECENT DEVELOPMENT
15.24 TERUMO MEDICAL CORPORATION
15.24.1 COMPANY SNAPSHOT
15.24.2 REVENUE ANALYSIS
15.24.3 PRODUCT PORTFOLIO
15.24.4 RECENT DEVELOPMENTS
15.25 MACHIDA ENDOSCOPE CO., LTD.
15.25.1 COMPANY SNAPSHOT
15.25.2 PRODUCT PORTFOLIO
15.25.3 RECENT DEVELOPMENTS
15.26 NALU MEDICAL, INC.
15.26.1 COMPANY SNAPSHOT
15.26.2 PRODUCT PORTFOLIO
15.26.3 RECENT DEVELOPMENT
15.27 WALLABY MEDICAL
15.27.1 COMPANY SNAPSHOT
15.27.2 PRODUCT PORTFOLIO
15.27.3 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
表格列表
TABLE 1 GLOBAL NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 2 GLOBAL NEUROSURGERY DEVICES IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 GLOBAL NEUROSURGERY DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 4 GLOBAL NEUROMODULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 5 GLOBAL INTERNAL NEUROMODULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 6 GLOBAL SPINAL CORD STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 7 GLOBAL DEEP BRAIN STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 8 GLOBAL SACRAL NERVE STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 9 GLOBAL VAGUS NERVE STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 10 GLOBAL GASTRIC ELECTRICAL STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 11 GLOBAL EXTERNAL NEUROMODULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 12 GLOBAL NEURO-INTERVENTIONAL DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 13 GLOBAL EMBOLIZATION COILS IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 14 GLOBAL NEUROVASCULAR THROMBECTOMY IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 15 GLOBAL NEUROSURGICAL POWER TOOLS IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 16 GLOBAL DRILL IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 17 GLOBAL CEREBROSPINAL FLUID (CSF) MANAGEMENT DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 18 GLOBAL NEUROSURGERY SOFTWARE IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 GLOBAL NEUROSURGERY SOFTWARE IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 20 GLOBAL CONSUMABLES IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 GLOBAL NEUROSURGERY MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 22 GLOBAL PEDIATRIC IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 GLOBAL ADULT IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 GLOBAL GERIATRIC IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 GLOBAL NEUROSURGERY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 26 GLOBAL BRAIN TUMORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 GLOBAL TRAUMA SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 GLOBAL SPINE SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 GLOBAL PARKINSON’S DISEASE AND TREMORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 GLOBAL PERIPHERAL NERVE SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 GLOBAL EPILEPSY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 32 GLOBAL FUNCTIONAL NEUROSURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 GLOBAL CAROTID ARTERY BLOCKAGE/STENOSIS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 GLOBAL INTERAOPERATIVE ANGIOGRAPHY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 GLOBAL CEREBROVASCULAR SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 GLOBAL ANEURYSMS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 GLOBAL PITUITARY TUMORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 38 GLOBAL RADIOSURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 39 GLOBAL STEREOTACTIC NEUROSURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 40 GLOBAL CORTICAL MAPPING IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 GLOBAL ARTERIOVENOUS MALFUNCTION (AVM) IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 42 GLOBAL SKULL BASE SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 43 GLOBAL TRIGEMINAL NEURALGIA IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 44 GLOBAL OTHERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 45 GLOBAL NEUROSURGERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 46 GLOBAL HOSPITALS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 47 GLOBAL HOSPITALS IN NEUROSURGERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 48 GLOBAL RESEARCH CENTERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 49 GLOBAL NEUROSURGERY CENTERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 50 GLOBAL AMBULATORY SURGICAL CENTERS (ASCS) IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 51 GLOBAL OTHERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 52 GLOBAL NEUROSURGERY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 53 GLOBAL DIRECT TENDER IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 54 GLOBAL THIRD PARTY DISTRIBUTORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 55 GLOBAL OTHERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
图片列表
FIGURE 1 GLOBAL NEUROSURGERY MARKET: SEGMENTATION
FIGURE 2 GLOBAL NEUROSURGERY MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL NEUROSURGERY MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL NEUROSURGERY MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 GLOBAL NEUROSURGERY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL NEUROSURGERY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL NEUROSURGERY MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 GLOBAL NEUROSURGERY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL NEUROSURGERY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL NEUROSURGERY MARKET: SEGMENTATION
FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL NEUROSURGERY MARKET, AND EUROPE IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 THE GROWING PREVALENCE OF NEUROLOGICAL DISEASES, EFFORTS TO DEVELOP THE APPLICATION BASE FOR NEUROMODULATION, AND THE BENEFITS OF NEUROENDOSCOPIC SURGERIES OVER CONVENTIONAL BRAIN SURGERIES ARE EXPECTED TO DRIVE THE GLOBAL NEUROSURGERY MARKET GROWTH IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 13 NEUROSURGERY DEVICES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL NEUROSURGERY MARKET IN 2022 & 2029
FIGURE 14 NORTH AMERICA IS THE FASTEST GROWING MARKET FOR NEUROSURGICAL PRODUCTS MANUFACTURERS IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND, CHALLENGES OF GLOBAL NEUROSURGERY MARKET
FIGURE 16 GLOBAL NEUROSURGERY MARKET: BY PRODUCT TYPE, 2021
FIGURE 17 GLOBAL NEUROSURGERY MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)
FIGURE 18 GLOBAL NEUROSURGERY MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 19 GLOBAL NEUROSURGERY MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 20 GLOBAL NEUROSURGERY MARKET: BY AGE GROUP, 2021
FIGURE 21 GLOBAL NEUROSURGERY MARKET: BY AGE GROUP, 2022-2029 (USD MILLION)
FIGURE 22 GLOBAL NEUROSURGERY MARKET: BY AGE GROUP, CAGR (2022-2029)
FIGURE 23 GLOBAL NEUROSURGERY MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 24 GLOBAL NEUROSURGERY MARKET: BY APPLICATION, 2021
FIGURE 25 GLOBAL NEUROSURGERY MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 26 GLOBAL NEUROSURGERY MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 27 GLOBAL NEUROSURGERY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 28 GLOBAL NEUROSURGERY MARKET: BY END USER, 2021
FIGURE 29 GLOBAL NEUROSURGERY MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 30 GLOBAL NEUROSURGERY MARKET: BY END USER, CAGR (2022-2029)
FIGURE 31 GLOBAL NEUROSURGERY MARKET: BY END USER, LIFELINE CURVE
FIGURE 32 GLOBAL NEUROSURGERY MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 33 GLOBAL NEUROSURGERY MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 34 GLOBAL NEUROSURGERY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 35 GLOBAL NEUROSURGERY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 36 GLOBAL NEUROSURGERY MARKET: SNAPSHOT (2021)
FIGURE 37 GLOBAL NEUROSURGERY MARKET: BY REGION (2021)
FIGURE 38 GLOBAL NEUROSURGERY MARKET: BY REGION (2022 & 2029)
FIGURE 39 GLOBAL NEUROSURGERY MARKET: BY REGION (2021 & 2029)
FIGURE 40 GLOBAL NEUROSURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 41 NORTH AMERICA NEUROSURGERY MARKET: SNAPSHOT (2021)
FIGURE 42 NORTH AMERICA NEUROSURGERY MARKET: BY COUNTRY (2021)
FIGURE 43 NORTH AMERICA NEUROSURGERY MARKET: BY PRODUCT COUNTRY (2022 & 2029)
FIGURE 44 NORTH AMERICA NEUROSURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 45 NORTH AMERICA NEUROSURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 46 EUROPE NEUROSURGERY MARKET: SNAPSHOT (2021)
FIGURE 47 EUROPE NEUROSURGERY MARKET: BY COUNTRY (2021)
FIGURE 48 EUROPE NEUROSURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 49 EUROPE NEUROSURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 50 EUROPE NEUROSURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 51 ASIA-PACIFIC NEUROSURGERY MARKET: SNAPSHOT (2021)
FIGURE 52 ASIA-PACIFIC NEUROSURGERY MARKET: BY COUNTRY (2021)
FIGURE 53 ASIA-PACIFIC NEUROSURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 54 ASIA-PACIFIC NEUROSURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 55 ASIA-PACIFIC NEUROSURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 56 SOUTH AMERICA NEUROSURGERY MARKET: SNAPSHOT (2021)
FIGURE 57 SOUTH AMERICA NEUROSURGERY MARKET: BY COUNTRY (2021)
FIGURE 58 SOUTH AMERICA NEUROSURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 59 SOUTH AMERICA NEUROSURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 60 SOUTH AMERICA NEUROSURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 61 MIDDLE EAST AND AFRICA NEUROSURGERY MARKET: SNAPSHOT (2021)
FIGURE 62 MIDDLE EAST AND AFRICA NEUROSURGERY MARKET: BY COUNTRY (2021)
FIGURE 63 MIDDLE EAST AND AFRICA NEUROSURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 64 MIDDLE EAST AND AFRICA NEUROSURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 65 MIDDLE EAST AND AFRICA NEUROSURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 66 GLOBAL NEUROSURGERY MARKET: COMPANY SHARE 2021 (%)
FIGURE 67 NORTH AMERICA NEUROSURGERY MARKET: COMPANY SHARE 2021 (%)
FIGURE 68 EUROPE NEUROSURGERY MARKET: COMPANY SHARE 2021 (%)
FIGURE 69 ASIA-PACIFIC NEUROSURGERY MARKET: COMPANY SHARE 2021 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
